Wang Q, Yang L, Quyang J, Long Q, Wang X
Biopharmaceutical Center, State Key Laboratory for Biological Control, Zhongshan University, Guangzhou 510275, China.
Wei Sheng Wu Xue Bao. 2001 Oct;41(5):582-6.
The 575 bp artificial synthesized human leukemia inhibitory factor (hLIF) gene was cloned into vector pPICZ alpha A and the constructed expression vector pPICZ alpha A-hLIF was linearized by SacI and transformed into Pichia pastoris X-33. After the screening for Mut phenotype and the PCR analysis of the transformants, hLIF gene expressed in Pichia pastoris. SDS-PAGE and Western blot analysis of the culture supernatants showed that hLIF gene could express as 58.5 kD protein with the desired immunogenicity. Density scanning of the SDS-PAGE gel revealed that the targeted protein accounted for 32.8% of the total protein in the supernatants. The expressed products can inhibit the clone formation of murine's teratoma cells.
将575 bp人工合成的人白血病抑制因子(hLIF)基因克隆到载体pPICZαA中,构建的表达载体pPICZαA-hLIF经SacI线性化后转化到毕赤酵母X-33中。经过Mut表型筛选和转化子的PCR分析,hLIF基因在毕赤酵母中表达。对培养上清液进行SDS-PAGE和Western blot分析表明,hLIF基因可表达为具有所需免疫原性的58.5 kD蛋白。SDS-PAGE凝胶的密度扫描显示,目标蛋白占上清液中总蛋白的32.8%。表达产物可抑制小鼠畸胎瘤细胞的克隆形成。